• Newton Biocapital invests in Flemish start-up DeuterOncology

    Wednesday February 24th 2021

  • QBD leerstoel voor precision oncology research in glioblastoma

    Wednesday February 17th 2021

  • Grapheal raises EUR1.9 million to advance development of embedded biosensing technology and application in digital COVID testing and wound monitoring

    Wednesday February 10th 2021

  • V-Bio Ventures launches its second fund at EUR 78 million

    Thursday February 4th 2021

  • Euronext Biotech Barometer H2 2020

    Monday February 1st 2021

  • reMYND extends Series B funding to EUR 24 million

    Thursday January 21st 2021

  • ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic

    Friday December 18th 2020

  • OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform

    Tuesday December 8th 2020

  • Your news here?

  • Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers

    Tuesday December 1st 2020

  • Novalis Biotech announces first closing of its second healthcare fund

    Tuesday November 24th 2020

  • Aphea.Bio secures €14 million Series B financing to further develop its next generation agricultural biologicals

    Friday November 20th 2020

Strategic Partners